Impact of Preeclampsia and Parity on Sex-based Discrepancies in Subclinical Carotid Atherosclerosis in Type 1 Diabetes.

IF 5 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Verónica Perea, Irene Vinagre, Tonet Serés-Noriega, Clara Viñals, Alex Mesa, Adriana Pané, Camila Milad, Enric Esmatjes, Ignacio Conget, Marga Giménez, Antonio J Amor
{"title":"Impact of Preeclampsia and Parity on Sex-based Discrepancies in Subclinical Carotid Atherosclerosis in Type 1 Diabetes.","authors":"Verónica Perea, Irene Vinagre, Tonet Serés-Noriega, Clara Viñals, Alex Mesa, Adriana Pané, Camila Milad, Enric Esmatjes, Ignacio Conget, Marga Giménez, Antonio J Amor","doi":"10.1210/clinem/dgad755","DOIUrl":null,"url":null,"abstract":"<p><strong>Context: </strong>The excess risk of fatal and nonfatal cardiovascular events is roughly twice as high in women than in men with type 1 diabetes.</p><p><strong>Objective: </strong>To evaluate the impact of preeclampsia and parity on sex-based discrepancies in preclinical atherosclerosis and on the diagnostic performance of a cardiovascular risk scale.</p><p><strong>Design: </strong>Cross-sectional study.</p><p><strong>Setting: </strong>Single tertiary hospital.</p><p><strong>Patients: </strong>A total of 728 people with type 1 diabetes (48.5% women) without cardiovascular disease and age ≥40 years, nephropathy, and/or ≥10 years of diabetes duration with another risk factor.</p><p><strong>Intervention: </strong>Standardized carotid ultrasonography.</p><p><strong>Main outcome measures: </strong>Carotid plaque determined by ultrasonography and cardiovascular risk estimated according to the Steno T1 Risk Engine (Steno-Risk).</p><p><strong>Results: </strong>Nulliparous women and parous women without previous preeclampsia had a lower risk for carotid plaque than men (adjusted odds ratio: .48, 95% confidence interval [.28-.82]; adjusted odds ratio: .51 [.33-.79], respectively), without differences in the preeclampsia group. The prevalence of carotid plaque increased as the estimated cardiovascular risk increased in all subgroups except for preeclampsia group. The area under the curve of the Steno-Risk for identifying ≥2 carotid plaques was lower in the preeclampsia group (men: .7886; nulliparous women: .9026; women without preeclampsia: .8230; preeclampsia group: .7841; P between groups = .042). Neither the addition of parity nor preeclampsia in the Steno-Risk led to a statistically significant increase in the area under the curve.</p><p><strong>Conclusion: </strong>The risk for carotid plaque in women compared with men decreased as exposure to obstetric factors diminished. However, the addition of these factors did not improve the prediction of the Steno-Risk.</p>","PeriodicalId":50238,"journal":{"name":"Journal of Clinical Endocrinology & Metabolism","volume":null,"pages":null},"PeriodicalIF":5.0000,"publicationDate":"2024-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Endocrinology & Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1210/clinem/dgad755","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Context: The excess risk of fatal and nonfatal cardiovascular events is roughly twice as high in women than in men with type 1 diabetes.

Objective: To evaluate the impact of preeclampsia and parity on sex-based discrepancies in preclinical atherosclerosis and on the diagnostic performance of a cardiovascular risk scale.

Design: Cross-sectional study.

Setting: Single tertiary hospital.

Patients: A total of 728 people with type 1 diabetes (48.5% women) without cardiovascular disease and age ≥40 years, nephropathy, and/or ≥10 years of diabetes duration with another risk factor.

Intervention: Standardized carotid ultrasonography.

Main outcome measures: Carotid plaque determined by ultrasonography and cardiovascular risk estimated according to the Steno T1 Risk Engine (Steno-Risk).

Results: Nulliparous women and parous women without previous preeclampsia had a lower risk for carotid plaque than men (adjusted odds ratio: .48, 95% confidence interval [.28-.82]; adjusted odds ratio: .51 [.33-.79], respectively), without differences in the preeclampsia group. The prevalence of carotid plaque increased as the estimated cardiovascular risk increased in all subgroups except for preeclampsia group. The area under the curve of the Steno-Risk for identifying ≥2 carotid plaques was lower in the preeclampsia group (men: .7886; nulliparous women: .9026; women without preeclampsia: .8230; preeclampsia group: .7841; P between groups = .042). Neither the addition of parity nor preeclampsia in the Steno-Risk led to a statistically significant increase in the area under the curve.

Conclusion: The risk for carotid plaque in women compared with men decreased as exposure to obstetric factors diminished. However, the addition of these factors did not improve the prediction of the Steno-Risk.

先兆子痫和奇偶性对 1 型糖尿病亚临床颈动脉粥样硬化性别差异的影响。
背景:1型糖尿病(T1D)女性患者发生致命性和非致命性心血管事件的超额风险大约是男性患者的两倍:评估先兆子痫和奇偶性对临床前动脉粥样硬化的性别差异以及心血管风险量表诊断性能的影响:横断面研究:患者728名T1D患者(48.5%为女性),无心血管疾病,年龄≥40岁,无肾病,和/或糖尿病病程≥10年且伴有其他危险因素:干预措施:标准化颈动脉超声检查:主要结果测量:通过超声波检查确定颈动脉斑块,并根据 Steno T1 风险引擎(Steno-Risk)估算心血管风险:结果:与男性相比,无先兆子痫的女性和有先兆子痫的女性患颈动脉斑块的风险较低(调整后的几率比 [OR]:0.48,95%置信区间[0.28-0.82];调整后的比值比[OR]:分别为0.51[0.33-0.79]),与先兆子痫组没有差异。除子痫前期组外,所有亚组的颈动脉斑块患病率都随着估计心血管风险的增加而增加。子痫前期组的 Steno-Risk 识别≥2 个颈动脉斑块的曲线下面积(AUC)较低(男性:0.7886,无先兆子痫女性:0.9026,无先兆子痫女性:0.8230,子痫前期组:0.7841;组间 P:0.7841):0.7841;组间 p=0.042)。在 Steno-Risk 中加入胎次和先兆子痫都不会导致 AUC 有统计学意义的增加:结论:与男性相比,女性患颈动脉斑块的风险随着产科因素的减少而降低。结论:与男性相比,女性患颈动脉斑块的风险会随着产科因素的减少而降低,但增加这些因素并不能改善对 Steno-Risk 的预测。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Clinical Endocrinology & Metabolism
Journal of Clinical Endocrinology & Metabolism 医学-内分泌学与代谢
CiteScore
11.40
自引率
5.20%
发文量
673
审稿时长
1 months
期刊介绍: The Journal of Clinical Endocrinology & Metabolism is the world"s leading peer-reviewed journal for endocrine clinical research and cutting edge clinical practice reviews. Each issue provides the latest in-depth coverage of new developments enhancing our understanding, diagnosis and treatment of endocrine and metabolic disorders. Regular features of special interest to endocrine consultants include clinical trials, clinical reviews, clinical practice guidelines, case seminars, and controversies in clinical endocrinology, as well as original reports of the most important advances in patient-oriented endocrine and metabolic research. According to the latest Thomson Reuters Journal Citation Report, JCE&M articles were cited 64,185 times in 2008.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信